search
for
 About Bioline  All Journals  Testimonials  Membership  News


Indian Journal of Surgery
Medknow Publications on behalf of Association of Surgeons of India
ISSN: 0972-2068
Vol. 64, No. 6, 2002, pp. 506-510
Bioline Code: is02006
Full paper language: English
Document type: Research Article
Document available free of charge

Indian Journal of Surgery, Vol. 64, No. 6, 2002, pp. 506-510

 en Total Versus Subtotal Thyroidectomy in Grave's Disease: A Retrospective Analysis
N. Dorairajan, M. Ramkumar, Korah T. Kuruvila, Scott Arockia Singh, Maniselvi, Preetha Muthayya

Abstract

Grave's disease is a relatively common condition occurring in 0.4% of the Indian Population. The treatment options for Grave's disease are radioactive iodine ablation, administration of anti-thyroid drugs and surgery. Both the non-surgical modalities require long-term continued patient follow up, which is not feasible in the Indian setup. Also, surgery is a rapid, consistent and effective method of making the patient euthyroid.15 Surgical treatment involves the removal of the thyroid gland either in entirety or a part of it. These procedures aim at reducing the thyroid gland volume to levels well below the "critical mass", which is believed to be the ideal volume of remnant producing no recurrence of hyperthyroidism and minimal hypothyroidism. The ideal surgical modality is still a matter of debate. This is a retrospective study that compares the advantages and disadvantages of total and subtotal thyroidectomy and comes to a conclusion that the former is a better treatment option particularly in the presence of exophthalmos.

Keywords
Grave's disease, Subtotal thyroidectomy, Total thyroidectomy, Critical mass

 
© Copyright 2002 Indian Journal of Surgery. Online full text also at http://www.indianjsurg.com/

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil